Skip to main content

Advertisement

Table 1 Characteristics of patients and their diagnosis

From: Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer

Characteristics FTS group (n = 128) Conventional group (n =132) P value
Median age 56.43 ± 13.28 55.72 ± 10.34 0.252
Gender    0.973
 Male 103 (80.5) 106 (80.3)  
 Female 25 (19.5) 26 (19.7)  
Weight (kg) 67.53 ± 14.37 66.45 ± 13.56 0.448
BMI (kg/m2) 22.53 ± 2.85 22.89 ± 2.56 0.272
Operating time (min) 168.98 ± 30.62 172.33 ± 24.67 0.438
Blood loss (ml) 302.54 ± 88.48 312. 33 ± 76.73 0.727
Operative incision    0.749
 One 44 (34.4) 48 (36.4)  
 Two 58 (45.3) 62 (46.9)  
 Three 26 (20.3) 22 (16.7)  
TNM    0.773
 I 39 (30.5) 36 (27.2)  
 II 71 (55.4) 79 (59.8)  
 III 18 (14.1) 17 (12.8)  
 IV 0 (0) 0 (0)  
Pathology    0.737
Adenocarcinoma 7 (5.5) 8 (6.1)  
Squamous cell carcinoma 116 (90.6) 121 (91.6)  
Other 5 (3.9) 3 (2.3)  
Tumor location    0.921
 Upper esophagus 12 (9.4) 14 (10.6)  
 Mid esophagus 73 (57.0) 76 (57.6)  
 Distal esophagus 43 (33.6) 42 (31.8)  
Neoadjuvant therapy    0.988
 Yes 68 (53.1) 70 (53.0)  
 No 60 (46.9) 62 (47.0)  
Neoadjuvant regimen    0.923
 Neoadjuvant chemoradiotherapy 27 (39.7) 25 (35.7)  
 Neoadjuvant chemotherapy 41 (60.3) 45 (64.3)  
 pCR after Neoadjuvant therapy 15 (22.1) 17 (24.2) 0.776
Surgical approach    0.953
 Conventional thoracotomy 62 (48.4) 66 (50.0)  
 Hybrid VATS 41 (32.0) 42 (31.8)  
 Pure VATS 25 (19.6) 24 (18.2)  
  1. Variables were expressed as the mean ± SD
  2. pCR pathologic complete response rates